These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25223892)

  • 1. Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?
    Haas J; Zilberberg E; Machtinger R; Kedem A; Hourvitz A; Orvieto R
    Gynecol Endocrinol; 2015 Jan; 31(1):79-82. PubMed ID: 25223892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to 450 IU during controlled ovarian hyperstimulation for IVF?].
    Haas J; Zilberberg E; Kedem A; Dar S; Orvieto R
    Harefuah; 2015 Feb; 154(2):114-7, 135. PubMed ID: 25856865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do poor-responder patients undergoing IVF benefit from splitting and increasing the daily gonadotropin dose?
    Ezra O; Haas J; Nahum R; Maman E; Cohen Y; Segev-Zahav A; Orvieto R
    Gynecol Endocrinol; 2019 Oct; 35(10):890-893. PubMed ID: 31032673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF.
    Orvieto R; Kirshenbaum M; Galiano V; Elkan-Miller T; Zilberberg E; Haas J; Nahum R
    Front Endocrinol (Lausanne); 2020; 11():182. PubMed ID: 32528403
    [No Abstract]   [Full Text] [Related]  

  • 9. Detrimental effects of high-dose gonadotropin on outcome of IVF: making a case for gentle ovarian stimulation strategies.
    Kovacs P; Sajgo A; Kaali SG; Pal L
    Reprod Sci; 2012 Jul; 19(7):718-24. PubMed ID: 22378863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios.
    Groen H; Tonch N; Simons AH; van der Veen F; Hoek A; Land JA
    Hum Reprod; 2013 Dec; 28(12):3236-46. PubMed ID: 24166594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R; Nahum R; Zohav E; Liberty G; Anteby EY; Meltcer S
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective egg freezing patients may benefit from increasing the maximal daily gonadotropin dose above 300IU.
    Orvieto R; Aizer A; Saar-Ryss B; Marom-Haham L; Noach-Hirsh M; Haas J; Nahum R
    Reprod Biol Endocrinol; 2022 Dec; 20(1):171. PubMed ID: 36536380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gonadotrophin dose and ovarian response: relations to the clinical outcome of in vitro fertilization and embryo transfer].
    Xiong XS; Chen SL; Sun L; Yin MN; Zhao EY; Song J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):712-4. PubMed ID: 18504186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of controlled ovarian hyperstimulation delayed, which occurs after functionally pituitary downregulation by depot GnRH agonist, on the outcome of in vitro fertilization and embryo transfer].
    Ma QH; Li SW; Huang ZY; Han ZY; Qiu DS; Han DW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):980-3. PubMed ID: 18095601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy.
    Lin YJ; Ou YC; Huang FJ; Lin PY; Kung FT; Lan KC
    J Minim Invasive Gynecol; 2013; 20(5):637-41. PubMed ID: 23706676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.
    Lindheim SR; Barad DH; Witt B; Ditkoff E; Sauer MV
    J Assist Reprod Genet; 1996 Oct; 13(9):745-7. PubMed ID: 8947826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response.
    Sekhon L; Shaia K; Santistevan A; Cohn KH; Lee JA; Beim PY; Copperman AB
    J Assist Reprod Genet; 2017 Jun; 34(6):749-758. PubMed ID: 28321529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation.
    Bercaire L; Nogueira SM; Lima PC; Alves VR; Donadio N; Dzik A; Cavagna M
    JBRA Assist Reprod; 2018 Mar; 22(1):52-55. PubMed ID: 29303236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical applications of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer].
    Wang L; Zhang WX; Jiang H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):910-4. PubMed ID: 23324190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.